Table 2

Utilities

ParameterUtility*Source
Disutility for experiencing a pneumonia0.079Biere et al13
Disutility for experiencing a chyle leakage†0Biere et al13
Disutility for experiencing laryngeal nerve paresis†0Biere et al13
Utility in the first 6 months in the no evidence of disease state0.729 (SD=0.259; n=32)Biere et al13
Utility after the first 6 months in the no evidence of disease state0.800 (SD=0.21; n=75)Doherty et al12
Utility in the residual LN metastases state0.780 (SD=0.2; n=30)Doherty et al12
Utility in the palliative care state0.740 (SD=0.19; n=26)Doherty et al12
  • *β-distributions were assigned to the parameters for use in the probabilistic sensitivity analysis. The characteristics of the β-distribution are presented between brackets, as an SD and n.

  • †Patients with chyle leakage and laryngeal nerve paresis had a higher utility than patients without complications, therefore the disutility was zero.

  • .LN, lymph node.